Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ebola Vaccine Trials Carry Risks for Companies in Chase
Bloomberg
Tuesday, October 21, 2014 - 8:12am
tags:
ebola virus, vaccines, GSK, JNJ, NewLink Genetics
Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant
Yahoo/Reuters
Tuesday, October 21, 2014 - 8:07am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A, David Pyott
Actelion Says U.S. Tax-Inversion Limits Good for Industry
Bloomberg
Tuesday, October 21, 2014 - 8:05am
tags:
Actelion, tax inversions, M&A
What's behind the huge price jump for some generic drugs?
LA Times, CA
Tuesday, October 21, 2014 - 8:05am
tags:
generics, drug pricing
Celgene Crohn's drug trial successful
Yahoo/Investors Business Daily
Tuesday, October 21, 2014 - 8:02am
tags:
Celgene, Crohn's Disease, Mongersen
Allergan files rebuttal to Valeant earnings
Marketwatch
Monday, October 20, 2014 - 6:48pm
tags:
Allergan, Valeant Pharmaceuticals, earnings, M&A
Actavis Said to Compete With Sanofi for Omega Pharma Deal
Bloomberg
Monday, October 20, 2014 - 6:37pm
tags:
Actavis, Sanofi, Omega Pharma, M&A
AbbVie says $55 billion acquisition of Shire officially dead
Yahoo/Reuters
Monday, October 20, 2014 - 6:36pm
tags:
AbbVie, Shire, M&A, tax inversions
Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe?
Yahoo/Zacks.com
Monday, October 20, 2014 - 6:34pm
tags:
GSK, China, bribery, earnings
Paulson Urges Allergan/Shire Tie-up
WSJ Online
Monday, October 20, 2014 - 12:44pm
tags:
Allergan, Shire, M&A
Valeant may raise Allergan bid, says it won't walk away
Yahoo/Reuters
Monday, October 20, 2014 - 11:38am
tags:
Valeant Pharmaceuticals, Allergan, M&A
Baxter prepping for HyQvia launch with spinoff's success on the line
Fierce Pharma
Monday, October 20, 2014 - 11:36am
tags:
Baxter International, HyQvia, primary immunodeficiency
First Detailed Look at Celgene Crohn's Disease Pill Impresses
TheStreet.com
Monday, October 20, 2014 - 10:55am
tags:
Celgene, Crohn's Disease, GED-0301
Genervon ALS drug shows encouraging results
Seeking Alpha
Monday, October 20, 2014 - 10:19am
tags:
Genevron, ALS, GM604
FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine
Yahoo
Monday, October 20, 2014 - 10:10am
tags:
FDA, Sanofi Pasteur, pediatric hexavalent vaccine, Merck, vaccines, diphtheria, tetanus, pertussis, Hib, hepatitis B
Could Galena Biopharma, Inc. Be Running Out of Money?
Motley Fool
Monday, October 20, 2014 - 9:47am
tags:
Galena Biopharma
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets
Yahoo
Monday, October 20, 2014 - 9:07am
tags:
Takeda, Orexigen, Contrave, obesity
Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit
Yahoo
Monday, October 20, 2014 - 8:44am
tags:
Hemispherx Biopharma
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Motley Fool
Monday, October 20, 2014 - 8:30am
tags:
JNJ, Gilead Sciences, Olysio, hepatitis C, Sovaldi
Biogen Expected To Report Positive Q3 Earnings
Bidness Etc.
Monday, October 20, 2014 - 8:23am
tags:
Biogen Idec, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.